Pasienter tatt inn i behandling i 2011 for problemer knyttet til bruk av narkotiske stoffer og vanedannende legemidler

2.50
Hdl Handle:
http://hdl.handle.net/10143/295283
Title:
Pasienter tatt inn i behandling i 2011 for problemer knyttet til bruk av narkotiske stoffer og vanedannende legemidler
Authors:
Lauritzen, Grethe; Amundsen, Ellen J.
Citation:
SIRUS-rapport 3/2013

Full metadata record

DC FieldValue Language
dc.contributor.authorLauritzen, Gretheen_GB
dc.contributor.authorAmundsen, Ellen J.en_GB
dc.date.accessioned2013-07-05T11:49:55Z-
dc.date.available2013-07-05T11:49:55Z-
dc.date.issued2013-06-
dc.identifier.citationSIRUS-rapport 3/2013en_GB
dc.identifier.isbn978-82-7171-402-4-
dc.identifier.urihttp://hdl.handle.net/10143/295283-
dc.description.abstractNORSK SAMMENDRAG: Rapporten redegjør for alders- og kjønnsfordeling for pasientene, hvilke rusmiddeldiagnoser som forekom i de ulike aldersgruppene og hvordan pasientene fordelte seg mellom behandlingsnivåene døgnbehandling og poliklinisk behandling. Nærmere 9000 pasienter påbegynte behandling for problemer knyttet til bruk av narkotiske stoffer og vanedannende medikamenter i 2011. En tredjedel av pasientene var kvinner og to tredeler menn. Kjønnsfordelingen varierte mellom de ulike aldersgruppene. Gjennomsnittsalderen var 34 år for kvinner og 35 år for menn. Problemer med opioider (herunder heroin) dominerte blant de som ble tatt inn i behandling. Rundt en tredel hadde dette som sin hoveddiagnose. Opp mot 30 prosent var diagnostisert med skadelig bruk eller avhengighet av flere narkotiske stoffer/medikamenter. Tidligere norske behandlingsstudier viser at opioider ofte inngår i et sammensatt rusmiddelproblem. Skadelig bruk eller avhengighet av cannabis utgjorde den tredje største gruppen med 18 prosent. Andelen cannabisbrukere i behandling var høyest blant unge pasienter. I aldersgruppene over 55 år var skadelig bruk eller avhengighet av vanedannende medikamenter den hyppigste begrunnelsen for behandling.en_GB
dc.description.abstractENGLISH SUMMARY: This report is based on material from the Norwegian Patient Registry (NPR) and concerns patients who were admitted to specialist treatment in 2011 for problems relating to harmful use or dependency on narcotic substances and addictive medications. The report accounts for age and gender distribution of patients, types of substance abuse diagnoses and the patients’ distribution between the treatment levels of residential and outpatient treatment. In 2011, 8,817 persons were reported to the NPR as starting treatment for harmful use of or dependency on narcotic substances and addictive medications. One third were women and two-thirds were men. The average age was 34 years for women and 35 years for men. About 20 per cent were under the age of 24, while 20 per cent were older than 44. The proportion of women varied with age. It was highest for the groups older than 55 and younger than 25 years. Problems with opioids (heroin, morphine, codeine, methadone, subutex, and others) dominated among those who were admitted for treatment (around 33 per cent). This proportion applied to both women and men. Nearly 30 per cent were diagnosed with harmful use or addiction to multiple narcotic substances/medications. Here too, no significant gender difference was found. Harmful use of or addiction to cannabis as a main diagnosis, comprised the third largest group, at 18 per cent. A greater proportion of men than women had such cannabis problems as their main diagnosis. Problems with cocaine comprised a small share (less than two per cent), whereas the share entering treatment for other stimulants was 13 per cent. No clear gender differences were found in these two groups. Around eight per cent were admitted to treatment for abuse of addictive medications (sedatives/hypnotics). Women were more prevalent than men among these patients. Drug abuse diagnoses were distributed unevenly among the age groups. The most comprehensive differences were encountered for cannabis and addictive medications. The use of cannabis appeared to be the main problem for patients in the youngest age groups, whereas addictive medications dominated among the oldest. This applied to both sexes. Patients whose major diagnoses involved use of opioids comprised about a third of those treated both at residential and outpatient treatment facilities. As regards patients whose main problem involved use of multiple psychoactive substances, a larger proportion was treated in residential facilities than in outpatient clinics. This also appertained to patient groups with sedatives/hypnotics and stimulants as their main substance diagnosis. Patients who had been diagnosed with harmful use of or addiction to cannabis were mainly treated in outpatient facilities. The criteria for extracting data from the NPR for this report relate to Norway’s obligations to contribute statistics to the EMCDDA, the European Monitoring Centre for Drugs and Drug Addiction. Patients who were treated primarily for their alcohol problems are left out of this data material. They are however included in other overviews. Annual reporting to the NPR will provide a national basis for evaluating changes in the treatment population in the course of time for various spheres of the specialist health services, and create an important source for future research.en_GB
dc.language.isonoen
dc.publisherSIRUSen_GB
dc.relation.ispartofseriesSIRUS-rapporten_GB
dc.relation.ispartofseries2013/3en_GB
dc.subject.meshRehabilitationen_GB
dc.subject.meshStreet Drugsen_GB
dc.subject.meshPrescription Drugsen_GB
dc.titlePasienter tatt inn i behandling i 2011 for problemer knyttet til bruk av narkotiske stoffer og vanedannende legemidlerno
dc.typeReporten
All Items in HeRA are protected by copyright, with all rights reserved, unless otherwise indicated.